The lack of concordance between PDEF and S100A7 or PDEF and B7-H4 expression in primary tumors underscores the need to confirm the cell line derived data in primary tumors, in order to determine the potential clinical significance of the specific gene expression changes observed in the gene-chip microarray screens of breast tumor cell lines. This evidence concerns the gene VTCN1 and breast neoplasm.